IL148038A0 - Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose - Google Patents
Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and riboseInfo
- Publication number
- IL148038A0 IL148038A0 IL14803801A IL14803801A IL148038A0 IL 148038 A0 IL148038 A0 IL 148038A0 IL 14803801 A IL14803801 A IL 14803801A IL 14803801 A IL14803801 A IL 14803801A IL 148038 A0 IL148038 A0 IL 148038A0
- Authority
- IL
- Israel
- Prior art keywords
- ribose
- carnitine
- dietary supplement
- energy metabolism
- muscular energy
- Prior art date
Links
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 title abstract 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 title abstract 2
- -1 alkanoyl carnitine Chemical compound 0.000 title abstract 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004203 carnitine Drugs 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 title 1
- 230000037149 energy metabolism Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000003387 muscular Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 206010002660 Anoxia Diseases 0.000 abstract 1
- 241000976983 Anoxia Species 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 206010049565 Muscle fatigue Diseases 0.000 abstract 1
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
- 230000007953 anoxia Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- IGQBPDJNUXPEMT-SNVBAGLBSA-N isovaleryl-L-carnitine Chemical compound CC(C)CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C IGQBPDJNUXPEMT-SNVBAGLBSA-N 0.000 abstract 1
- 230000002107 myocardial effect Effects 0.000 abstract 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- 230000037081 physical activity Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000RM000323A IT1317043B1 (it) | 2000-06-14 | 2000-06-14 | Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio. |
| PCT/IT2001/000283 WO2001095915A1 (en) | 2000-06-14 | 2001-06-01 | Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL148038A0 true IL148038A0 (en) | 2002-09-12 |
Family
ID=11454786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14803801A IL148038A0 (en) | 2000-06-14 | 2001-06-01 | Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US20030108537A1 (xx) |
| EP (1) | EP1292312B1 (xx) |
| AT (1) | ATE265216T1 (xx) |
| AU (1) | AU782367B2 (xx) |
| CA (1) | CA2381339C (xx) |
| CZ (1) | CZ2002366A3 (xx) |
| DE (1) | DE60103055T2 (xx) |
| DK (1) | DK1292312T3 (xx) |
| ES (1) | ES2219531T3 (xx) |
| HU (1) | HU228642B1 (xx) |
| IL (1) | IL148038A0 (xx) |
| IT (1) | IT1317043B1 (xx) |
| MX (1) | MXPA02001550A (xx) |
| NO (1) | NO20020731L (xx) |
| PL (1) | PL199641B1 (xx) |
| PT (1) | PT1292312E (xx) |
| SK (2) | SK287308B6 (xx) |
| TR (1) | TR200401096T4 (xx) |
| WO (1) | WO2001095915A1 (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20020545A1 (it) * | 2002-10-30 | 2004-04-30 | Chementecno Srl | Integratore energetico e vitaminico minerale ad azione ergogenica per la prevenzione della fatica muscolare. |
| GB0306394D0 (en) * | 2003-03-20 | 2003-04-23 | Univ Nottingham | Carnitine retention |
| CA2529317A1 (en) * | 2003-06-26 | 2004-12-29 | Donald M. Mcleod | Supplement for restoring growth hormone levels |
| GB0606864D0 (en) * | 2006-04-05 | 2006-05-17 | Univ Nottingham | Increades fatty acid oxidation |
| BRPI0806231A2 (pt) * | 2007-01-23 | 2011-09-06 | Bioenergy Inc | método para utilização da d-ribose no tratamento de arritimias cardìacas |
| CN101356971B (zh) * | 2007-07-30 | 2012-11-07 | 石药集团中奇制药技术（石家庄）有限公司 | 一种用于抗疲劳耐缺氧的保健食品组合物 |
| EP2323668A1 (en) * | 2008-08-20 | 2011-05-25 | Bioenergy Inc. | Use of d-ribose for fatigued subjects |
| GB2510374A (en) * | 2013-01-31 | 2014-08-06 | Christopher Francis Bennett | Formulation comprising N-acetylcarnitine and D-ribose |
| GB201304112D0 (en) * | 2013-03-07 | 2013-04-24 | Univ Nottingham | Modulation of energy expenditure |
| US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| CN108473384A (zh) | 2015-10-27 | 2018-08-31 | 细胞酶动物营养品公司 | 动物营养成分及相关方法 |
| ITUB20155250A1 (it) * | 2015-11-24 | 2017-05-24 | Apuzzo Dario | Nuova composizione nutraceutica, somministrabile per via orale, utile per esercitare una potente stimolazione del metabolismo, in particolare del metabolismo energetico muscolare. |
| DE102016002090A1 (de) | 2016-02-22 | 2017-08-24 | Ribomedica S. L. | Komposition für die Nahrungsergänzung menschlicher Ernährung und deren Verwendung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988001861A1 (en) * | 1986-09-17 | 1988-03-24 | Baxter Travenol Laboratories, Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |
| US6294520B1 (en) * | 1989-03-27 | 2001-09-25 | Albert T. Naito | Material for passage through the blood-brain barrier |
| US5397786A (en) * | 1993-01-08 | 1995-03-14 | Simone; Charles B. | Rehydration drink |
| IT1291127B1 (it) | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
| US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
| DE69929128T2 (de) * | 1998-08-31 | 2006-06-29 | Nipro Corp. | Nährstoffinfusionspräparat |
| US6579544B1 (en) * | 2000-05-31 | 2003-06-17 | Nutriex, L.L.C. | Method for supplementing the diet |
-
2000
- 2000-06-14 IT IT2000RM000323A patent/IT1317043B1/it active
-
2001
- 2001-01-06 US US10/048,590 patent/US20030108537A1/en not_active Abandoned
- 2001-04-24 SK SK1729-2002A patent/SK287308B6/sk not_active IP Right Cessation
- 2001-06-01 PT PT01941001T patent/PT1292312E/pt unknown
- 2001-06-01 WO PCT/IT2001/000283 patent/WO2001095915A1/en active IP Right Grant
- 2001-06-01 DK DK01941001T patent/DK1292312T3/da active
- 2001-06-01 ES ES01941001T patent/ES2219531T3/es not_active Expired - Lifetime
- 2001-06-01 TR TR2004/01096T patent/TR200401096T4/xx unknown
- 2001-06-01 PL PL352578A patent/PL199641B1/pl unknown
- 2001-06-01 AU AU74487/01A patent/AU782367B2/en not_active Ceased
- 2001-06-01 DE DE60103055T patent/DE60103055T2/de not_active Expired - Lifetime
- 2001-06-01 MX MXPA02001550A patent/MXPA02001550A/es active IP Right Grant
- 2001-06-01 SK SK210-2002A patent/SK2102002A3/sk unknown
- 2001-06-01 CA CA002381339A patent/CA2381339C/en not_active Expired - Fee Related
- 2001-06-01 CZ CZ2002366A patent/CZ2002366A3/cs unknown
- 2001-06-01 HU HU0202496A patent/HU228642B1/hu not_active IP Right Cessation
- 2001-06-01 IL IL14803801A patent/IL148038A0/xx unknown
- 2001-06-01 EP EP01941001A patent/EP1292312B1/en not_active Expired - Lifetime
- 2001-06-01 AT AT01941001T patent/ATE265216T1/de active
-
2002
- 2002-02-13 NO NO20020731A patent/NO20020731L/no not_active Application Discontinuation
-
2006
- 2006-11-27 US US11/604,390 patent/US20070116743A1/en not_active Abandoned
-
2010
- 2010-04-02 US US12/753,368 patent/US8518455B2/en not_active Expired - Fee Related
-
2013
- 2013-07-26 US US13/952,083 patent/US8747906B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL148038A0 (en) | Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose | |
| WO2006086667A3 (en) | Antisense composition and method for treating muscle atrophy | |
| CA2213339A1 (en) | Method of treating adenosine depletion | |
| WO1998043499A3 (en) | Nutritional supplement | |
| EP1039887A4 (en) | PROCESS FOR THE TREATMENT OF NEURO AND NEPHROTOXICITIES AND THERAPEUTIC TOXICITIES WITH AMINOTHIOL COMPOUNDS | |
| HUP0004439A3 (en) | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders | |
| BG103646A (en) | Arylsulphonamides, their analogues and application for the treatment of neurodegenerative diseases | |
| EP0787489A3 (xx) | ||
| US8252309B2 (en) | Dietary supplement energy-providing to skeletal muscles | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| NZ509276A (en) | Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects | |
| CA2228281A1 (en) | Use of l-carnitine and acyl l-carnitines for lowering ceramide levels | |
| CA2253130A1 (en) | A medicament for treating obesity and improving lipid metabolism | |
| WO2001026666A3 (en) | Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba | |
| CA2335015A1 (en) | Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug | |
| MX9703810A (es) | Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro. | |
| TR200002894T2 (tr) | L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon | |
| MX9706971A (es) | Derivado de aminotetralina para la terapia de las enfermedades cardiovasculares. | |
| PL367812A1 (en) | Alpha-ketoglutarates of active ingredients and compositions containing same | |
| ATE361677T1 (de) | Nahrungsmittelergänzung, welche liponsäure und kreatin enthält und methoden zu deren anwendung | |
| EP1219297A4 (en) | ACTIVE AGENTS AGAINST FATTY ADDICTION | |
| TNSN00150A1 (fr) | Composition cardioactive comprenant l-carnitine et ses derives et des extraits d'aubepine (crataegus) | |
| Silverman | What are the effects of creatine supplementation on performance? | |
| US20070117867A1 (en) | Kit comprising three independent compositions and methods for building muscle, increasing strength, increasing muscle size, increasing muscle performance and reducing muscle fatigue | |
| Chmurzyńska et al. | MTX does not affect enhanced biosynthesis and metabolism of S-adenosylmethionine in testosterone-induced hypertrophic mouse kidney |